HIGHLIGHTS
- who: Aline Miranda Scovino from the Instituto Microbiologia Paulo Goes, Universidade federal do, Brazil, Instituto Oswaldo have published the research: SARS-CoV-2u2019s Variants of Concern: A Brief Characterization, in the Journal: (JOURNAL) of December/31,/2019
- what: This study showed that the effectiveness of this vaccine against the alpha variant was 89.5% to develop the disease and 97.4% against severe and fatal cases of the disease . This work evaluated the efficacy of two attenuated virus vaccines, CoronaVac/Sinovac and BBIBPCorV vaccine, as well as an adenovirus vector vaccine, Cansino`s Ad5 vaccine . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.